New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Vaccinex, Inc.
VCNX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

5M

Biotechnology

Next Earning date - 11 Nov 2024

5M

Biotechnology

Next Earning date - 11 Nov 2024

2.82USD
Shape-0.24 ( -7.84%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

16%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated October 3, 2024
1W -17.26 % 1M -46.33 % 3M -58.13 % 1Y -78.84 %

Key Metrics

Shape
  • Market Cap

    4.87M


  • Shares Outstanding

    1.73M


  • Share in Float

    865510


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    2.82


  • Average Volume

    82809


  • Beta

    0.98


  • Range

    2.79-18.06


  • Industry

    Biotechnology


  • Website

    https://www.vaccinex.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

-1.85x

P/B Ratio

-0.0

Debt/Equity

59190.0%

Net Margin

$-4.0

EPS

How VCNX compares to sector?

P/E Ratio

Relative Strength

Shape

VCNX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$143M

Shape61409%

2025-Revenue

$258.30

Shape8432%

2025-EPS

$143M

Shape-2405%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-27.30
vs -44.10

Q3.22

arrow
arrow

N/A

-23.10
vs -35.70

Q4.22

arrow
arrow

N/A

-23.10
vs -31.50

Q1.23

arrow
arrow

N/A

-21.00
vs -25.20

Q2.23

arrow
arrow

N/A

-25.20
vs -27.30

Q3.23

arrow
arrow

N/A

-15.27
vs -23.10

Q4.23

arrow
arrow

N/A

-39.40
vs -23.10

Q1.24

arrow
arrow

N/A

-2.94
vs -21.00

Q2.24

arrow
arrow

N/A

-3.10
vs -25.20

Q3.24

arrow
arrow

+110%

1.54
vs -15.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

50K  vs 50K

Q4.22

arrow
arrow

-94%

50K  vs 850K

Q1.23

arrow
arrow

NA

550K  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-60%

20K  vs 50K

Q4.23

arrow
arrow

-872%

-386000.00  vs 50K

Q1.24

arrow
arrow

-81%

104K  vs 550K

Q2.24

arrow
arrow

NA

232K  vs NA

Q3.24

arrow
arrow

+1075%

234.9K  vs 20K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-75%

-0.75
vs -0.49

Q4.22

arrow
arrow

-97%

-0.97
vs -0.75

Q1.23

arrow
arrow

-206%

-2.06
vs -0.97

Q2.23

arrow
arrow

+1669%

16.69
vs -2.06

Q3.23

arrow
arrow

+127%

1.27
vs 16.69

Q4.23

arrow
arrow

+144%

1.44
vs 1.27

Q1.24

arrow
arrow

-147%

-1.47
vs 1.44

Q2.24

arrow
arrow

+197%

1.97
vs -1.47

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

22

22
vs 27

-19%

Q1.22

arrow
arrow

27

27
vs 22

23%

Q2.22

arrow
arrow

28

28
vs 27

4%

Q3.22

arrow
arrow

20

20
vs 28

-29%

Q4.22

arrow
arrow

27

27
vs 20

35%

Q1.23

arrow
arrow

26

26
vs 27

-4%

Q2.23

arrow
arrow

24

24
vs 26

-8%

Q4.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News